中文

← All funding rounds

Venomics AI

Drug discoveryBengaluru, IndiaFounded 2026Private

Sequences animal venoms collected across India, measures what their peptides do against human drug targets by electrophysiology in its own lab, and keeps the results as the Venom Atlas, a dataset of venom peptides tied to measured activity. Models built on open foundations such as ESM and AlphaFold are trained on it to rank candidates, flag toxicity and redesign venom scaffolds; its stated targets are ion channels, in pain, cardiac and insulin signalling, and insecticidal peptides for crop pests.

Disclosed total$2.7M
Rounds on record1
Latest round$2.7MPre-seed · 2026-04
Last stated valuationNone stated
Investors named3
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date2026$2.7M
Closed round

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-04Pre-seed
    Round

    $2.7M

    For: expand the Venom Atlas dataset, strengthen AI and laboratory screening, hire across venom biology, computational science and drug discovery, and take the first steps toward lead programmes

    Data generationModels and platformWet lab

    Speciale Invest's post of 4 November 2026 says it is leading the round; Inc42 and BioSpectrum India, both of 5 November, call it co-led by Speciale Invest and South Park Commons with Operators Studio participating, so both are recorded as leads. The company's own site dates the $2.7M to April 2026, which is the date kept here; no valuation and no cumulative total were disclosed.

    Co-lead · Speciale Invest ✓Co-lead · South Park CommonsOperators Studio

    On the deal: Sunil Cavale (Wrote the firm's post announcing the investment, Speciale Invest)

    The investor's own page says · Speciale Invest: Speciale Invest's own post says it is leading the $2.7M pre-seed round in Venomics AI.

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

On the investors' own sites

Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.

  • Speciale InvestSpeciale Invest's own post says it is leading the $2.7M pre-seed round in Venomics AI. · Leadspecialeinvest.com ↗